+240.7%
DOCN vs SBAC
-6.8%
+247.5%
-61.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | SBAC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +9.6% | -0.7% | +10.3% | +9.5% |
| 7D | +3.7% | -2.8% | +6.5% | +3.5% |
| 30D | -33.7% | +3.1% | -36.8% | -33.4% |
| 3M | -27.9% | +5.1% | -33.0% | -27.6% |
| 6M | -46.4% | -11.4% | -35.0% | -45.9% |
| YTD | +81.1% | +0.2% | +80.9% | +81.2% |
| 1Y | +74.3% | -3.9% | +78.2% | +74.6% |
| All | +240.7% | -6.8% | +247.5% | +242.4% |
Cumulative growth
Daily Returns
Daily percentage return beside SBAC.
Daily Out/Under-Performance
Portfolio return minus SBAC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SBAC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded SBAC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling